By maximising both sensitivity and specificity for prediction of lung cancer, a cut-point of 2.1 mg l−1 was identified for levels of CRP (sensitivity and specificity both 61%) and of 68.6 μg l−1 for levels of YKL-40 (sensitivity and specificity both 62%). The gene discussed is CRP; the disease is lung carcinoma.